Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Colon stimulation" does **not** refer to a specific molecule, protein, receptor, enzyme, or other discrete therapeutic target. Instead, it describes the *physiological process* of activating or enhancing the motor and/or secretory functions of the colon. This can be achieved through various means—such as electrical stimulation[5], pharmacological agents acting on neurotransmitter receptors (e.g., serotonin receptors like 5‑HT4)[2][6], neuropeptides[2], and interventions targeting autonomic pathways[3]—but "colon stimulation" itself is not an entity that can be classified with molecular attributes. The term encompasses multiple mechanisms and pathways: - **Motor function regulation** involves neural (cholinergic/acetylcholine-mediated), humoral (neuropeptides), and local reflexes affecting smooth muscle contraction in the colon wall[2]. - **Secretory function regulation** includes chloride-driven fluid secretion mediated by transport proteins such as CFTR and NKCC1 under control of cAMP/Ca²⁺ signaling pathways[1]. - Both functions are relevant for conditions like constipation or irritable bowel syndrome but do not represent a single druggable target. Because "colon stimulation" refers to an action/process rather than a defined molecular entity: > The entry is incorrect for use as a canonical therapeutic target; it should be replaced with specific molecules/receptors involved in colonic motility or secretion regulation such as "5-hydroxytryptamine receptor 4", "muscarinic acetylcholine receptor", etc.[2][6] No standard abbreviation exists for this term in scientific literature. There are no direct aliases; related terms might include “colonic motility enhancement” or “colonic neuromodulation,” but these also describe processes rather than targets. In summary, "colon stimulation" should not be treated as a valid molecular target entry. It represents complex physiological processes involving many different molecules and regulatory systems rather than one discrete druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colon stimulation.